This your MUST READ from @DrTedrosnytimes.com/2021/04/22/opi… “First, vaccine nationalism has weakened Covax, with a handful of rich countries gobbling up the anticipated supply as manufacturers sell to the highest bidder, while the rest of the world scrambles for the scraps.”
“Second, vaccine diplomacy has undermined Covax as countries with vaccines make bilateral donations for reasons that have more to do with geopolitical goals than public health.”nytimes.com/2021/04/22/opi…
“Third, vaccine hesitancy has hampered the rollout of vaccines, through the same combination of myth and misinformation that has enabled measles to resurge around the world.”nytimes.com/2021/04/22/opi…
“And fourth, a new trend — let’s call it vaccine euphoria — is undermining hard-won gains as some countries relax public health measures too quickly and some people assume that vaccines have ended the pandemic, at least where they live.”nytimes.com/2021/04/22/opi…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
As #SriLanka tries to understand airborne transmission of #COVID19 - here is a thread of four key papers published in the @TheLancet & @bmj_latest (I’m sure there are more) to provide answers to what is airborne transmission and how to prevent it. @MoH_SriLanka@HPBSriLanka
Key takeaways in terms of prevention from this paper is to limit indoor gatherings/increase ventilation indoor settings/mask wearing/ prevention efforts of only plastic barriers do not work cz the virus can spread through air via tiny droplets esp. indoor settings. #COVID19SL
The media conference on #COVID19 of #SriLanka has key takeaways so far: a)airborne indoor transmission risk is high b) quarantine back to 14 for returnees c) so far no solutions for public transport challenges d) request to cancel major public events such as horse races etc.
e) vaccine second doses will be administered during May to priority candidates then others after f) Sinopharm is awaiting WHO approval within two weeks g) Sputnik V regular vaccines are expected
Also, government officials say "we are at the mercy of manufacturers" which is a global challenge. The govt. has allocated money also with the support of the World Bank etc. but if manufacturing bottlenecks interfere that will impact the supply of vaccines.